Equilab International has been distinguished as the leading Contract Research Organization (CRO) in Indonesia and Southeast Asia since 2003. We are consistent in being the pioneer in providing our best services and supporting our customers to go through the global market. Equilab provides main services in Bioavailability/Bioequivalence (BA/BE) Studies, Clinical Trials, Laboratory Testing, and Dermatology Testing. 

 

By 2024, Equilab has completed over 1,500 successful projects. We have established strong partnerships with more than 100 international clients from the Americas, Asia, Oceania, Europe, Africa, local, and multinational corporations. Additionally, we have collaborated with more than 300 domestic partners in Indonesia. Our clinical study reports (CSRs) have been recognized and approved from over 40 nations, including regulatory bodies such as the WHO and UK-MHRA.